ibrutinib
SpainDrugs containing this active substance
-
It is used in adults to treat certain types of blood cancers: Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), and Waldenström's Macroglobulinemia (WM).
Form: tablets, film-coated
Active substance Dosage ibrutinib 140 mg Manufacturer: Janssen-Cilag International N.V
-
It is used in adults to treat certain types of blood cancers: Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), and Waldenström's Macroglobulinemia (WM).
Form: capsules, hard
Active substance Dosage ibrutinib 140 mg Manufacturer: Janssen-Cilag International N.V
-
It is used in adults to treat certain types of blood cancers, such as Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), and Waldenström Macroglobulinemia (WM).
Form: tablets, film-coated
Active substance Dosage ibrutinib 280 mg Manufacturer: Janssen-Cilag International N.V
-
It is used in adults to treat certain types of blood cancers, such as Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, and Waldenström Macroglobulinemia.
Form: tablets, film-coated
Active substance Dosage ibrutinib 420 mg Manufacturer: Janssen-Cilag International N.V
-
It is used in adults to treat certain types of blood cancers: Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), and Waldenström Macroglobulinemia (WM).
Form: tablets, film-coated
Active substance Dosage ibrutinib 560 mg Manufacturer: Janssen-Cilag International N.V